The health headlines move fast and most coverage gets the science wrong. Every day, Dr. Ravi Kumar, MD, a board-certified neurosurgeon, cuts through the noise: what a new study or story actually says, what it doesn’t, and what it means for you. Researched, sourced, and reviewed before it’s published.
Generics are still far cheaper per prescription, but Americans take so many of them that they paid $16.8 billion out of pocket for generics in a year versus $13.7 billion for brand-name drugs, so if you fill several generics, it is worth asking your pharmacist whether the cash price beats your copay.
A Houston pharmacy is recalling six lots of injectable glutathione, Myers' Cocktail and Tri-Immune Boost shipped nationwide because the glutathione carried a bacterial toxin, so if you had one of these injections or drips, check whether it came from Centric Compounding, throw out any recalled vials at home, and tell your doctor if you had fever, chills or chest pain afterward.
In a German study of 400 adults with diabetes, days when blood sugar moved around more than usual, while staying inside safe limits, were followed by better quality of life, which suggests that chasing a perfectly flat line may not be worth the effort, though it gives no license to run high.
CDC warned on September 10 that rabies exposures and post-bite shots are rising nationwide, and the practical message is simple: if a wild animal or a pet with unknown vaccine status bites or scratches you, wash the wound with soap and water right away and call your doctor or health department the same day.
Three studies presented at the European Respiratory Society Congress found smoking rates falling while vaping, dual use and early nicotine use climbed, with the average starting age dropping from 20 to about 15.
If you already qualify for a GLP-1 drug because of diabetes or obesity and you also have asthma, this is worth raising with your doctor; if you do not qualify, it is not yet a reason to seek one for your lungs.
A new study of 826 young working men found erectile dysfunction in more than half of the highest stress group, but the design cannot show that stress caused it, and new erectile trouble in a young man is still a reason to get blood pressure, blood sugar and sleep checked.
A study of 60,980 US adults with autoimmune rheumatic conditions found that people who got a booster or the 2023-2024 updated COVID shot were far less likely to be hospitalized than people who stopped after the original series.
A University of Glasgow study of nearly half a million UK adults found the lowest death rates sat 1 to 3 g/dL above the official anemia cutoff, meaning some results currently labeled normal carried a small but measurable extra risk.
The trial answered the standard objection to failed vitamin D studies, that the dose was fixed and blood levels were never checked. It still could not tell a real benefit apart from chance.
In 129,287 US adults, the number of days on a first Z-drug prescription predicted whether patients were still filling sleeping pills seven years later.
A study of 216,293 adults with type 2 diabetes found a lower five-year risk of atrial fibrillation in people who started an SGLT2 inhibitor than in those who started a GLP-1 drug, and no extra benefit from adding a GLP-1 on top.